Search research articles
Contact Us
Filters
Showing results (251-260 of 316) with videos related to
Page
of 32
Sort By:
Pediatric Blood & Cancer
|
June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG
Chizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 23, 2007
Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma
Amy M Gillis, Elizabeth Sutton, Kelly D Dewitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2011
Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems
Swati S More, Melissa Itsara, Xiaodong Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531
Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial
Steven G DuBois, Louis Chesler, Susan Groshen, et al.
Pediatric Blood & Cancer
|
September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma
Alekist Quach, Lingyun Ji, Vikash Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database
Daniel A Morgenstern, Wendy B London, Derek Stephens, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 10, 2017
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation
Richard Li, Alexei Polishchuk, Steven DuBois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study
Lars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 316) with videos related to
Sort By:
Page
of 32
Pediatric Blood & Cancer
|
June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG
Chizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 23, 2007
Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma
Amy M Gillis, Elizabeth Sutton, Kelly D Dewitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2011
Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems
Swati S More, Melissa Itsara, Xiaodong Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531
Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial
Steven G DuBois, Louis Chesler, Susan Groshen, et al.
Pediatric Blood & Cancer
|
September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma
Alekist Quach, Lingyun Ji, Vikash Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database
Daniel A Morgenstern, Wendy B London, Derek Stephens, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 10, 2017
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation
Richard Li, Alexei Polishchuk, Steven DuBois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study
Lars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
Page
of 32